icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
eNq1mF1v2jAUhu/5FVEudkcSCnSwJVQboxtSqzFatGk3yCQHMDN26g8+9uvnENpSlKirwZfY5vXxOcePXyW82iyJswIuMKORW/MC1wEaswTTWeSO7q+rLfeqUwkXaIUOlul13sWF68QECRG52aw3AUSF9+v25gvo/wN3OxUnZJMFxPLFOiUx8b4hMb9FabbGCVcMJ84S5JwlkZsquRt1QiG5jqKzZvyPSFEMob8fOZxdjBuH46Gfif2HqhLAbxCdFYoCNdKMFedAZRdJmDG+LYm3bqSNxRAEUzyGAZLzAWcrnEBSuMUUEQFGm0zXyR3wFQGZbVIo7i/ipTASRwu0GcJDvzjoT3q2KzeyGlRr72uN4DJoB0Gz3TTaih+kqrgK+hB+PK41m41Gve4D9WFLABlWZsC4RMRSTbDovmwrS/tweHi19gkWKUFbbyFS01QhjvQ0cH357R0kO8E91zgiOmdH+lQR4r8x6tEeFpYizljUZYrKEmZcD00T0WVUwqa8omaYk5t9L2IQ55P9y2gx4gdqQnBsCjSNHAVCjob9cp6dDwWfkYARt8eCn5gmbC3Oz5jDmlqKPt1hslA05UltfNFuXeoyGF+h37qBSl6XnuIsBV/TB4tToNKnU3YqTnRPFks9duSZmnHncFiMCJR4nLEhV3QXPloya31u7w7lE4WiX3v3ps3xQwHf3u1+FkrjJHoqqxl0bZBct+JrgT/65AjoO7RMP+aXOErH9aDZatcbu8GDRSeQwYpvVryYOHMpU/HB99frtTdHoiqQzq835WXvwdVxIo7O/TR2nCBTID/X257Zt2IPcruUw9hS6JP8lX1bYU2v9msG4lRTvP//3nwX7iG5ghNqkb8C1ljd750f/8+O2FrYgxfQsbfNzr0iiRm15avUpFDxtAdH15Vecw2I79MpLvn4UtqXoZ9/+OlUQj/76NOp/APBcgpR
ZB7TPSkZVcSRPuPX